Filing Details
- Accession Number:
- 0001209191-11-012093
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-02-23 17:07:23
- Reporting Period:
- 2011-02-18
- Filing Date:
- 2011-02-23
- Accepted Time:
- 2011-02-23 17:07:23
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1318459 | Michael Paul Antinori | 8 Sylvan Way Parsippany NJ 07054 | Sr. Vp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2011-02-18 | 2,667 | $17.45 | 34,193 | No | 4 | A | Direct | |
Common Stock | Disposition | 2011-02-18 | 500 | $17.45 | 33,693 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-02-22 | 1,462 | $17.28 | 32,231 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Option (right to buy) | Acquisiton | 2011-02-18 | 13,333 | $17.45 | 13,333 | $17.45 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
13,333 | 2021-02-18 | No | 4 | A | Direct |
Footnotes
- The range of prices for the transactions reported on this line is between $17.10 and $17.61 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- The option vests in 48 equal monthly installments beginning on 3/18/2011.